Table 4 Indications for CS among women in group 1
Indication | Absolute contribution to the CS rate in group 1, %, 2014 | Absolute contribution to the CS rate in group 1, %, 2016 | p value | Absolute contribution to the overall CS rate, %, 2014 | Absolute contribution to the overall CS rate, %, 2016 | p value |
|---|---|---|---|---|---|---|
FC (without oxytocin) | 15.9 54/340 | 17.3 53/294 | p = 0.472 | 1.5 54/3502 | 1.4 53/3526 | p = 0.101 |
Dystocia | 74.1252/340 | 75.5225/294 | p = 0.484 | 7.2252/3502 | 6.3225/3526 | p = 0.174 |
CCD without oxytocin | 10.0 34/340 | 10.5 31/294 | p = 0.818 | 1.0 34/3502 | 0.9 31/3526 | p = 0.689 |
CCD with oxytocin | 20.0 68/340 | 16.0 47/294 | p = 0.19 | 2.9 68/3502 | 1.3 47/3526 | p = 0.044 |
ICD without oxytocin | 6.2 21/340 | 7.1 21/294 | p = 0.624 | 0.6 21/3502 | 0.6 21/3526 | p = 0.984 |
ICD with oxytocin | 27.9 95/340 | 33.0100/294 | p = 0.099 | 2.7 95/3502 | 2.8100/3526 | p = 0.757 |
FC with oxytocina | 10.0 34/340 | 8.8 26/294 | p = 0.617 | 1.0 34/3502 | 0.7 26/3526 | p = 0.289 |
Others | 10.0 34/340 | 7.1 22/294 | p = 0.267 | 1.0 34/3502 | 0.6 22/3526 | p = 0.101 |
Total | 9.7340/3502 | 8.5300/3526 | p = 0.08 |